mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.07 |
0.2 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
A-804598 |
CTRPv2 |
pan-cancer |
AAC |
-0.054 |
0.2 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.056 |
0.2 |
mRNA |
BMS-536924 |
CTRPv2 |
pan-cancer |
AAC |
0.043 |
0.2 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.039 |
0.2 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
Topotecan |
CTRPv2 |
pan-cancer |
AAC |
-0.038 |
0.2 |
mRNA |
cabozantinib |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.2 |